All In MedTech

Device Trial Radar · NCT03958357

Post Market Clinical Follow-up Study Venezia

Multi-center Prospective Observational Clinical Follow-Up Study Advanced Gynecological Applicator - Venezia Configuration

Last checked: Nov 20, 2026Latest source record: Apr 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

41

Actual

Start

Apr 10, 2019

Primary completion

Jul 26, 2021

Study completion May 3, 2022

Sponsor

Lead sponsor
Nucletron Operations BVNot on our public-company list
Sponsor type
Industry
Collaborators
Factory CRO
First posted
May 22, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigational device is the Advanced Gynecological Applicator (AGA) Venezia configuration, an applicator to treat locally advanced stage cervical cancer. The goal of the study is to assess the performance and the unknown risks or complications of the AGA Venezia configuration during clinical use of the applicator.

Conditions

  • Cervical Cancer

Interventions

  • Advanced Gynecological Applicator configurationDevice

    The Advanced Gynecological Applicator Venezia configuration is a gynaecological applicator for intracavitary and interstitial brachytherapy. The applicator consists of tubes, caps and templates to place needles, which can be combined to reach a wide range of target areas. The tubes and possibly used needles, guide the radioactive source of the afterloader to the target volume. Dose optimization and dose fractionation is performed with the goal of adapting the dose to the target volume without exceeding the dose volume constraints for the surrounding normal tissues according to the standard cervical cancer treatment of the centre.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance of the AGA Venezia configuration applicator as assessed by the 'Applicator Performance Questionnaire'Time frame: Within one week after each individual insertion. No change is assessed. The procedure is performed per hospital standard. On average, the procedure and applicator insertions are performed twice.

Locations

3 sites in 3 countries. Site status is shown where the registry gives one.

  • Medical University Vienna

    Vienna, Austria

  • Ludwig-Maximilians - University of Munich

    Munich, Germany

  • University Medical Centre Utrecht

    Utrecht, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.